Atacand plus 8/12.5 mg
Atacand plus 8/12.5 mg is a medicine authorised by Swissmedic under authorisation number 54875. The authorisation holder is Cheplapharm Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 March 1999 and the authorisation is valid without a time limit. ATC code C09DA06 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 54875 |
|---|---|
| Name | Atacand plus 8/12.5 mg |
| Full name | Atacand plus 8/12.5 mg, Tabletten |
| Authorisation holder | Cheplapharm Schweiz GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DA06 |
| First authorisation | 24 March 1999 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Atacand plus 8/12.5 mg, Tabletten | B | 24 March 1999 |
| 2 | Atacand plus 16/12.5 mg, Tabletten | B | 29 December 1999 |
| 3 | Atacand plus 32/12.5 mg, Tabletten | B | 04 August 2009 |
| 4 | Atacand plus 32/25 mg, Tabletten | B | 04 August 2009 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 29 | 28 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 37 | 98 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 2 | 30 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 53 | 28 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 61 | 98 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 90 | 28 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 91 | 98 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 93 | 28 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 94 | 98 | Tablette(n) | C09DA06 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Atacand plus 8/12.5 mg authorised in Switzerland?
Yes. Atacand plus 8/12.5 mg is authorised by Swissmedic under authorisation number 54875, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Atacand plus 8/12.5 mg have?
Atacand plus 8/12.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Atacand plus 8/12.5 mg?
The authorisation holder is Cheplapharm Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.